Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | IGF1R | P08069 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | GLS | O94925 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL769785 | 0.85 | PPARA (0.39) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL770265 | 0.83 | SMN1; SMN2 (0.43) | POLBSMN1; SMN2GLS | |
| SCHEMBL17354072 | 0.83 | CALM1 (0.45) | CALM1F2RL1ALDH1A1KDM4EPOLB | |
| SCHEMBL769798 | 0.82 | CALM1 (0.44) | CALM1F2RL1ALDH1A1KDM4EPOLB | |
| SCHEMBL769795 | 0.81 | CYP1A2 (0.48) | KDM4ESMN1; SMN2GLS | |
| SCHEMBL6011833 | 0.80 | TAAR1 (0.59) | CALM1F2RL1ALDH1A1KDM4ETAAR1 | |
| SCHEMBL770505 | 0.74 | CALM1 (0.45) | CALM1F2RL1ALDH1A1KDM4ETAAR1 | |
| SCHEMBL17354076 | 0.72 | SMN1; SMN2 (0.43) | F2RL1POLBTAAR1SMN1; SMN2GLS | |
| SCHEMBL17354078 | 0.71 | PPARA (0.34) | CALM1F2RL1ALDH1A1KDM4EPOLB | |
| SCHEMBL19755183 | 0.71 | CALM1 (0.61) | CALM1F2RL1POLBTAAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9217921-B2 | Resist underlayer film forming composition containing silicon having sulfide bond | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-22 | — | — | US | disclosed |
| US-20120070994-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICON HAVING SULFIDE BOND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120070994-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICON HAVING SULFIDE BOND | SMC3, SRSF3, SRSF9 | CALM1 3261/4885F2RL1 1836/4885ALDH1A1 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.